Daré Bioscience (DARE) Short Interest Ratio & Short Volume $3.17 +0.01 (+0.32%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.15 -0.02 (-0.63%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Daré Bioscience Short Interest DataDaré Bioscience (DARE) has a short interest of 87,600 shares, representing 1.02% of the float (the number of shares available for trading by the public). This marks a -4.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 22,920 shares to cover all short positions.Current Short Interest87,600 sharesPrevious Short Interest91,500 sharesChange Vs. Previous Month-4.26%Dollar Volume Sold Short$284,700.00Short Interest Ratio2.0 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares8,700,000 sharesFloat Size8,560,000 sharesShort Percent of Float1.02%Today's Trading Volume55,041 sharesAverage Trading Volume22,920 sharesToday's Volume Vs. Average240% Short Selling Daré Bioscience? Sign up to receive the latest short interest report for Daré Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDARE Short Interest Over TimeDARE Days to Cover Over TimeDARE Percentage of Float Shorted Over Time Daré Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202587,600 shares $284,700.00 -4.3%1.0%2 $3.25 1/15/202591,500 shares $304,695.00 +5.7%1.1%1.9 $3.33 12/31/202486,600 shares $270,192.00 +50.9%1.0%1.7 $3.12 12/15/202457,400 shares $182,532.00 +2.9%0.7%1.1 $3.18 11/30/202455,800 shares $190,836.00 +118.8%0.7%1.4 $3.42 11/15/202425,500 shares $81,855.00 -13.3%0.3%0.6 $3.21 10/31/202429,400 shares $124,362.00 -33.9%0.4%0.7 $4.23 10/15/202444,500 shares $156,195.00 +14.7%0.5%1.2 $3.51 9/30/202438,800 shares $125,712.00 +9.6%0.5%1 $3.24 9/15/202435,400 shares $117,174.00 -9.7%0.4%0.8 $3.31 Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 8/31/202439,200 shares $140,336.00 +19.9%0.5%0.8 $3.58 8/15/202432,700 shares $113,796.00 +51.4%0.4%0.7 $3.48 7/31/202421,600 shares $74,088.00 -63.3%0.3%0.5 $3.43 7/15/202458,900 shares $198,493.00 +68.3%0.7%0.9 $3.37 6/30/202435,000 shares $141,162.00 -79.8%0.4%0.5 $4.03 6/15/2024172,900 shares $77,770.42 -71.2%N/A0.3 $0.45 5/31/2024600,200 shares $246,082.00 +12.6%N/A0.9 $0.41 5/15/2024532,900 shares $191,844.00 +83.6%N/A0.7 $0.36 4/30/2024290,300 shares $89,267.25 +17.6%N/A0.4 $0.31 4/15/2024246,900 shares $118,536.69 +5.1%N/A0.6 $0.48 3/31/2024235,000 shares $115,197.00 -48.5%N/A0.6 $0.49 3/15/2024456,200 shares $213,684.08 -14.0%N/A1.1 $0.47 2/29/2024530,500 shares $304,507.00 +5.2%N/A0.8 $0.57 2/15/2024504,200 shares $184,385.94 -10.1%N/A0.8 $0.37 1/31/2024560,900 shares $182,292.50 -11.3%N/A1 $0.33 1/15/2024632,000 shares $229,795.20 -27.3%N/A1.1 $0.36 12/31/2023869,800 shares $268,768.20 -11.2%N/A1.6 $0.31 12/15/2023979,200 shares $344,580.48 +76.8%N/A2 $0.35 11/30/2023553,900 shares $193,865.00 +23.9%N/A1.3 $0.35 11/15/2023447,000 shares $152,963.40 -22.6%N/A1.8 $0.34 10/31/2023577,300 shares $247,084.40 +0.9%N/A2.5 $0.43 10/15/2023572,300 shares $263,258.00 -4.7%N/A2.4 $0.46 9/30/2023600,300 shares $277,218.54 +4.8%N/A2.2 $0.46 9/15/2023572,800 shares $292,128.00 -31.6%N/A1.9 $0.51 8/31/2023836,800 shares $572,622.24 +19.4%N/A2.7 $0.68 8/15/2023700,900 shares $515,091.41 +11.6%N/A2.4 $0.73 7/31/2023628,300 shares $469,151.61 -9.3%N/A2.2 $0.75 7/15/2023692,400 shares $602,388.00 +45.1%N/A2.6 $0.87 6/30/2023477,100 shares $434,208.71 +29.4%N/A2.2 $0.91 6/15/2023368,600 shares $353,856.00 +7.6%N/A1.9 $0.96$5,000 DOGE check? (Ad)Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.Everything you need to know is right here. 5/31/2023342,600 shares $346,026.00 -9.5%N/A1.8 $1.01 5/15/2023378,600 shares $382,386.00 -25.9%N/A2 $1.01 4/30/2023511,000 shares $511,000.00 -16.6%N/A2.5 $1.00 4/15/2023612,400 shares $618,524.00 +12.5%N/A2.2 $1.01 3/31/2023544,400 shares $566,176.00 +16.8%N/A1.8 $1.04 3/15/2023466,000 shares $466,000.00 -15.9%N/A1.5 $1.00 2/28/2023554,100 shares $576,264.00 -49.6%N/A1.8 $1.04 2/15/20231,100,000 shares $1.24 million -38.6%N/A3.5 $1.13 1/31/20231,790,000 shares $2.27 million +51.7%N/A5.7 $1.27 1/15/20231,180,000 shares $1.42 million -13.2%N/A5.1 $1.20 12/30/20221,360,000 shares $1.13 million +33.3%N/A5.7 $0.83 12/15/20221,020,000 shares $922,080.00 -12.8%N/A4.1 $0.90 11/30/20221,170,000 shares $1.04 million +4.5%N/A4.5 $0.89 11/15/20221,120,000 shares $1.06 million -0.9%N/A4.1 $0.95 10/31/20221,130,000 shares $1.10 million -8.1%N/A3.8 $0.97 10/15/20221,230,000 shares $1.10 million -12.1%N/A3.7 $0.89 9/30/20221,400,000 shares $1.40 million -0.7%N/A3.6 $1.00 9/15/20221,410,000 shares $1.55 million -3.4%N/A2.2 $1.10 8/31/20221,460,000 shares $1.58 million -2.7%N/A2 $1.08 8/15/20221,500,000 shares $1.89 million +2.7%N/A1.8 $1.26 7/31/20221,460,000 shares $1.62 million -0.7%N/A1.6 $1.11 7/15/20221,470,000 shares $1.81 million -24.6%N/A1.4 $1.23 6/30/20221,950,000 shares $2.40 million +18.9%N/A1.7 $1.23 6/15/20221,640,000 shares $2.00 million -15.9%N/A1.2 $1.22 5/31/20221,950,000 shares $2.40 million -14.5%N/A1.4 $1.23 5/15/20222,280,000 shares $2.39 million -1.7%N/A1.6 $1.05 4/30/20222,320,000 shares $2.62 million +10.0%N/A1.5 $1.13 4/15/20222,110,000 shares $2.89 million +1.0%N/A1.2 $1.37 3/31/20222,090,000 shares $3.11 million -2.8%N/A1 $1.49 3/15/20222,150,000 shares $3.14 million -8.9%N/A0.9 $1.46 2/28/20222,360,000 shares $3.52 million +7.8%N/A0.4 $1.49 2/15/20222,190,000 shares $3.48 million -17.7%N/A0.4 $1.59 1/31/20222,660,000 shares $4.18 million -22.7%N/A0.5 $1.57 1/15/20223,440,000 shares $5.71 million -6.0%N/A0 $1.66 12/31/20213,660,000 shares $7.32 million -39.6%N/A0.7 $2.00 12/15/20216,060,000 shares $11.15 million +227.6%N/A1.1 $1.84 11/30/20211,850,000 shares $3.33 million +4.5%N/A0.4 $1.80 11/15/20211,770,000 shares $3.06 million -22.4%N/A0.8 $1.73 10/29/20212,280,000 shares $3.33 million +72.7%N/A0.8 $1.46 10/15/20211,320,000 shares $2.07 million -20.5%N/A0.4 $1.57 9/30/20211,660,000 shares $2.77 million -48.0%N/A0.4 $1.67 9/15/20213,190,000 shares $5.33 million -31.3%N/A0.3 $1.67 8/31/20214,640,000 shares $8.12 million -3.1%N/A0.5 $1.75 8/13/20214,790,000 shares $7.66 million +8.9%N/A0.5 $1.60 7/30/20214,400,000 shares $6.78 million -16.2%9.5%0.5 $1.54 7/15/20215,250,000 shares $8.45 million +126.3%11.4%0.7 $1.61 6/30/20212,320,000 shares $4.38 million +82.7%5.0%0.3 $1.89 6/15/20211,270,000 shares $1.70 million -0.8%2.8%1.6 $1.34 5/28/20211,280,000 shares $1.64 million -1.5%2.8%1.6 $1.28 5/14/20211,300,000 shares $1.61 million +12.1%N/A1.4 $1.24$5,000 DOGE check? (Ad)Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.Everything you need to know is right here. 4/30/20211,160,000 shares $1.75 million +0.9%N/A1 $1.51 4/15/20211,150,000 shares $1.73 million -6.5%N/A0 $1.50 3/31/20211,230,000 shares $2.03 million +1.7%N/A0.4 $1.65 3/15/20211,210,000 shares $2.69 million +0.8%N/A0.4 $2.22 2/26/20211,200,000 shares $2.32 million -16.1%N/A0.4 $1.93 2/12/20211,430,000 shares $3.42 million +10.9%N/A0.5 $2.39 1/29/20211,290,000 shares $2.79 million +126.5%N/A0.4 $2.16 1/15/2021569,500 shares $877,030.00 -22.9%N/A0.2 $1.54 12/31/2020738,400 shares $967,304.00 +41.3%N/A0.7 $1.31 12/15/2020522,600 shares $600,990.00 +51.1%N/A0.5 $1.15 11/30/2020345,900 shares $466,965.00 +44.8%N/A0.4 $1.35 11/15/2020238,900 shares $258,012.00 -4.6%N/A0.4 $1.08 10/30/2020250,400 shares $245,392.00 +296.8%N/A0.5 $0.98 10/15/202063,100 shares $67,517.00 -45.2%N/A0.1 $1.07 9/30/2020115,200 shares $115,050.24 -38.3%N/A0.1 $1.00 9/15/2020186,600 shares $207,126.00 +15.3%N/A0.2 $1.11 8/31/2020161,900 shares $174,852.00 -20.8%N/A0.2 $1.08 8/14/2020204,500 shares $233,130.00 -50.2%N/A0.2 $1.14 7/31/2020410,400 shares $455,544.00 +58.6%N/A0.5 $1.11 7/15/2020258,800 shares $326,088.00 -1.6%N/A0.3 $1.26 6/30/2020263,100 shares $260,100.66 +52.6%N/A0.7 $0.99 6/15/2020172,400 shares $170,762.20 -13.9%N/A0.5 $0.99 5/29/2020200,300 shares $208,312.00 -16.5%N/A0.6 $1.04 5/15/2020239,900 shares $244,698.00 -35.4%N/A0.6 $1.02 4/30/2020371,600 shares $412,476.00 +119.8%N/A0.9 $1.11 4/15/2020169,100 shares $172,735.65 -34.1%N/A0.4 $1.02 3/31/2020256,500 shares $266,760.00 +10.6%N/A0.2 $1.04 3/13/2020231,900 shares $208,710.00 -29.5%N/A0.5 $0.90 2/28/2020328,700 shares $259,673.00 +10.7%N/A0.2 $0.79 DARE Short Interest - Frequently Asked Questions What is Daré Bioscience's current short interest? Short interest is the volume of Daré Bioscience shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 87,600 shares of DARE short. 1.02% of Daré Bioscience's shares are currently sold short. Learn More on Daré Bioscience's current short interest. What is a good short interest ratio for Daré Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DARE shares currently have a short interest ratio of 2.0. Learn More on Daré Bioscience's short interest ratio. Which institutional investors are shorting Daré Bioscience? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Daré Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Daré Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.02% of Daré Bioscience's floating shares are currently sold short. Is Daré Bioscience's short interest increasing or decreasing? Daré Bioscience saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 87,600 shares, a decrease of 4.3% from the previous total of 91,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Daré Bioscience's float size? Daré Bioscience currently has issued a total of 8,700,000 shares. Some of Daré Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Daré Bioscience currently has a public float of 8,560,000 shares. How does Daré Bioscience's short interest compare to its competitors? 1.02% of Daré Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Daré Bioscience: Procaps Group S.A. (0.12%), Enanta Pharmaceuticals, Inc. (16.92%), Skye Bioscience, Inc. (10.22%), Atossa Therapeutics, Inc. (7.35%), XBiotech Inc. (4.65%), Aligos Therapeutics, Inc. (21.83%), Editas Medicine, Inc. (20.70%), Zura Bio Limited (10.40%), Anixa Biosciences, Inc. (1.32%), Adverum Biotechnologies, Inc. (12.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Daré Bioscience stock? Short selling DARE is an investing strategy that aims to generate trading profit from Daré Bioscience as its price is falling. DARE shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Daré Bioscience? A short squeeze for Daré Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further. How often is Daré Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies PROC Short Squeeze ENTA Short Squeeze SKYE Short Squeeze ATOS Short Squeeze XBIT Short Squeeze ALGS Short Squeeze EDIT Short Squeeze ZURA Short Squeeze ANIX Short Squeeze ADVM Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DARE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
